Cancer Treatment Services International (CTSI), a wholly owned subsidiary of Varian Medical Systems Inc. (a Siemens Healthineers Company) has announced its new Chief Executive Officer (CEO)- Harish Trivedi for South Asia.

Trivedi will be responsible for steering the operations of American Oncology Institute (Cancer Treatment Services Hyderabad), Citizens Specialty Hospital (Artmed Healthcare) and Ampath (American Institute of Pathology and Laboratory Sciences) in the Indian Subcontinent. He will be based out of Hyderabad Corporate Office and will be reporting to Dr Jagprag Singh Gujral, SVP MDO / Head of Emerging Markets, Group CEO CTSI.  

With over 25+ years of rich healthcare experience, Trivedi will be responsible for driving and overseeing the development and execution of the hospital’s strategy, quality excellence, and patient relationship management.  

He transitioned to healthcare delivery over the last decade and has had accomplished healthcare stints with Fortis Healthcare, Max Healthcare and Apollo Hospitals, where he has been instrumental in strategising and restructuring key functions. He holds a master’s degree in management from the University of Mumbai with an impressive track record in various industries (like General Mills, Pepsico, Tata Tele and Reliance Retail). 

Image caption- From left to right - Dr Jagprag Singh Gujral, SVP MDO  Head of Emerging Markets, Group CEO CTSI welcoming Harish Trivedi the new CEO CTSI South Asia